Thrombospondin expression in myofibers stabilizes muscle membranes

eLife

Volumn 5, Issue September2016, 2016, Pages

  Vanhoutte, Davy ^a   Schips, Tobias G ^a   Kwong, Jennifer Q ^a   Davis, Jennifer ^a   Tjondrokoesoemo, Andoria ^a   Brody, Matthew J ^a   Sargent, Michelle A ^a   Kanisicak, Onur ^a   Yi, Hong ^b   Gao, Quan Q ^c   Rabinowitz, Joseph E ^d   Volk, Talila ^e   McNally, Elizabeth M ^c   Molkentin, Jeffery D ^a,f  

^a UNIVERSITY OF CINCINNATI   (United States)

^b EMORY UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; MEMBRANE PROTEIN; MESSENGER RNA; THROMBOSPONDIN; THROMBOSPONDIN 4; UNCLASSIFIED DRUG;

ADULT; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; DISEASE MODEL; DROSOPHILA; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; INTRACELLULAR TRANSPORT; MALE; MEMBRANE STABILIZATION; MEMBRANE TRANSPORT; MOLECULAR STABILITY; MOUSE; MUSCLE CELL; MUSCLE FIBER MEMBRANE; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; MYOTATIC REFLEX; NONHUMAN; PROTEIN EXPRESSION; SARCOLEMMA; SKELETAL MUSCLE; TREADMILL TEST; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION; MEMBRANE; METABOLISM; MUSCLE FIBRIL; PATHOPHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA; GENE EXPRESSION; MEMBRANES; MICE; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MYOFIBRILS; THROMBOSPONDINS;

EID: 84991625071     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.17589     Document Type: Article

References (67)

1. Adams JC, Lawler J. 2011. The thrombospondins. Cold Spring Harbor Perspectives in Biology 3:a009712. doi: 10.1101/cshperspect.a009712
2. Allikian MJ, Bhabha G, Dospoy P, Heydemann A, Ryder P, Earley JU, Wolf MJ, Rockman HA, McNally EM. 2007. Reduced life span with heart and muscle dysfunction in Drosophila sarcoglycan mutants. Human Molecular Genetics 16:2933-2943. doi: 10.1093/hmg/ddm254
3. Allikian MJ, Hack AA, Mewborn S, Mayer U, McNally EM. 2004. Genetic compensation for sarcoglycan loss by integrin alpha7beta1 in muscle. Journal of Cell Science 117:3821-3830. doi: 10.1242/jcs.01234
4. Ambily A, Kaiser WJ, Pierro C, Chamberlain EV, Li Z, Jones CI, Kassouf N, Gibbins JM, Authi KS. 2014. The role of plasma membrane STIM1 and Ca(2+)entry in platelet aggregation. STIM1 binds to novel proteins in human platelets. Cellular Signalling 26:502-511. doi: 10.1016/j.cellsig.2013.11.025
5. Baek KH, Bhang D, Zaslavsky A, Wang LC, Vachani A, Kim CF, Albelda SM, Evan GI, Ryeom S. 2013. Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors. Journal of Clinical Investigation 123:4375-4389. doi: 10.1172/JCI67465
6. Bakay M, Wang Z, Melcon G, Schiltz L, Xuan J, Zhao P, Sartorelli V, Seo J, Pegoraro E, Angelini C, Shneiderman B, Escolar D, Chen YW, Winokur ST, Pachman LM, Fan C, Mandler R, Nevo Y, Gordon E, Zhu Y, et al. 2006. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 129:996-1013. doi: 10.1093/brain/awl023
7. Barrett T, Edgar R. 2006. Mining microarray data at NCBI’s gene expression omnibus (GEO)*. Methods in Molecular Biology 338:175-190. doi: 10.1385/1-59745-097-9:175
8. Bornstein P. 2001. Thrombospondins as matricellular modulators of cell function. Journal of Clinical Investigation 107:929-934. doi: 10.1172/JCI12749
9. Bouvard D, Pouwels J, De Franceschi N, Ivaska J. 2013. Integrin inactivators: balancing cellular functions in vitro and in vivo. Nature Reviews Molecular Cell Biology 14:430-442. doi: 10.1038/nrm3599
10. Brandizzi F, Barlowe C. 2013. Organization of the ER-Golgi interface for membrane traffic control. Nature Reviews Molecular Cell Biology 14:382-392. doi: 10.1038/nrm3588
11. Brody MJ, Schips TG, Vanhoutte D, Kanisicak O, Karch J, Maliken BD, Blair NS, Sargent MA, Prasad V, Molkentin JD. 2016. Dissection of thrombospondin-4 domains involved in intracellular adaptive ER Stress responsive signaling. Molecular and Cellular Biology 36:2-12. doi: 10.1128/MCB.00607-15
12. Burr AR, Molkentin JD. 2015. Genetic evidence in the mouse solidifies the calcium hypothesis of myofiber death in muscular dystrophy. Cell Death and Differentiation 22:1402-1412. doi: 10.1038/cdd.2015.65
13. Cai C, Masumiya H, Weisleder N, Matsuda N, Nishi M, Hwang M, Ko JK, Lin P, Thornton A, Zhao X, Pan Z, Komazaki S, Brotto M, Takeshima H, Ma J. 2009. MG53 nucleates assembly of cell membrane repair machinery. Nature Cell Biology 11:56-64. doi: 10.1038/ncb1812
14. Carlson CB, Lawler J, Mosher DF. 2008. Structures of thrombospondins. Cellular and Molecular Life Sciences: CMLS 65:672-686. doi: 10.1007/s00018-007-7484-1
15. Chanana B, Graf R, Koledachkina T, Pflanz R, Vorbrüggen G. 2007. AlphaPS2 integrin-mediated muscle attachment in Drosophila requires the ECM protein thrombospondin. Mechanisms of Development 124:463-475. doi: 10.1016/j.mod.2007.03.005
16. Chen YW, Zhao P, Borup R, Hoffman EP. 2000. Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology. The Journal of Cell Biology 151:1321-1336. doi: 10.1083/jcb.151. 6.1321
17. Chlenski A, Guerrero LJ, Salwen HR, Yang Q, Tian Y, Morales La Madrid A, Mirzoeva S, Bouyer PG, Xu D, Walker M, Cohn SL. 2011. Secreted protein acidic and rich in cysteine is a matrix scavenger chaperone. PLoS One 6: e23880. doi: 10.1371/journal.pone.0023880
18. Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A, Lawler J, Mosher DF, Bornstein P, Barres BA. 2005. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120:421-433. doi: 10.1016/j.cell.2004.12.020
19. De Franceschi N, Hamidi H, Alanko J, Sahgal P, Ivaska J. 2015. Integrin traffic-the update. Journal of Cell Science 128:839-852. doi: 10.1242/jcs.161653
20. Duquette M, Nadler M, Okuhara D, Thompson J, Shuttleworth T, Lawler J. 2014. Members of the thrombospondin gene family bind stromal interaction molecule 1 and regulate calcium channel activity. Matrix Biology 37:15-24. doi: 10.1016/j.matbio.2014.05.004
21. Duquette M, Sadow PM, Lawler J, Nucera C. 2013. Thrombospondin-1 silencing down-regulates integrin expression levels in human anaplastic thyroid cancer cells with BRAF(V600E): new insights in the host tissue adaptation and homeostasis of tumor microenvironment. Frontiers in Endocrinology 4:189. doi: 10.3389/fendo. 2013.00189
22. Durbeej M, Campbell KP. 2002. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Current Opinion in Genetics & Development 12:349-361. doi: 10.1016/S0959-437X(02)00309-X
23. Frolova EG, Drazba J, Krukovets I, Kostenko V, Blech L, Harry C, Vasanji A, Drumm C, Sul P, Jenniskens GJ, Plow EF, Stenina-Adognravi O. 2014. Control of organization and function of muscle and tendon by thrombospondin-4. Matrix Biology 37:35-48. doi: 10.1016/j.matbio.2014.02.003
24. Frolova EG, Pluskota E, Krukovets I, Burke T, Drumm C, Smith JD, Blech L, Febbraio M, Bornstein P, Plow EF, Stenina OI. 2010. Thrombospondin-4 regulates vascular inflammation and atherogenesis. Circulation Research 107:1313-1325. doi: 10.1161/CIRCRESAHA.110.232371
25. Frolova EG, Sopko N, Blech L, Popovic ZB, Li J, Vasanji A, Drumm C, Krukovets I, Jain MK, Penn MS, Plow EF, Stenina OI. 2012. Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload. The FASEB Journal 26:2363-2373. doi: 10.1096/fj.11-190728
26. Glembotski CC. 2007. Endoplasmic reticulum stress in the heart. Circulation Research 101:975-984. doi: 10. 1161/CIRCRESAHA.107.161273
27. Goddeeris MM, Wu B, Venzke D, Yoshida-Moriguchi T, Saito F, Matsumura K, Moore SA, Campbell KP. 2013. LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy. Nature 503:136-140. doi: 10.1038/nature12605
28. Goonasekera SA, Lam CK, Millay DP, Sargent MA, Hajjar RJ, Kranias EG, Molkentin JD. 2011. Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. Journal of Clinical Investigation 121: 1044-1052. doi: 10.1172/JCI43844
29. Gray SJ, Choi VW, Asokan A, Haberman RA, McCown TJ, Samulski RJ. 2011. Production of recombinant adeno-associated viral vectors and use in in vitro and in vivo administration. Current Protocols in Neuroscience Chapter 4. Unit 4.17. doi: 10.1002/0471142301.ns0417s57
30. Grounds MD, Sorokin L, White J. 2005. Strength at the extracellular matrix-muscle interface. Scandinavian Journal of Medicine and Science in Sports 15:381-391. doi: 10.1111/j.1600-0838.2005.00467.x
31. Gumerson JD, Michele DE. 2011. The dystrophin-glycoprotein complex in the prevention of muscle damage. Journal of Biomedicine and Biotechnology 2011:1-13. doi: 10.1155/2011/210797
32. Hack AA, Lam MY, Cordier L, Shoturma DI, Ly CT, Hadhazy MA, Hadhazy MR, Sweeney HL, McNally EM. 2000. Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. Journal of Cell Science 113 (Pt 14):2535-2544.
33. Hauser N, Paulsson M, Kale AA, DiCesare PE. 1995. Tendon extracellular matrix contains pentameric thrombospondin-4 (TSP-4). FEBS Letters 368:307-310. doi: 10.1016/0014-5793(95)00675-Y
34. Hewett JW, Kamm C, Boston H, Beauchamp R, Naismith T, Ozelius L, Hanson PI, Breakefield XO, Ramesh V. 2004. TorsinB-perinuclear location and association with torsinA. Journal of Neurochemistry 89:1186-1194. doi: 10.1111/j.1471-4159.2004.02404.x
35. Hirschberg K, Miller CM, Ellenberg J, Presley JF, Siggia ED, Phair RD, Lippincott-Schwartz J. 1998. Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. The Journal of Cell Biology 143:1485-1503. doi: 10.1083/jcb.143.6.1485
36. Hiscott P, Seitz B, Schlo¨ tzer-Schrehardt U, Naumann GO. 1997. Immunolocalisation of thrombospondin 1 in human, bovine and rabbit cornea. Cell and Tissue Research 289:307-310. doi: 10.1007/s004410050877
37. John AS, Rothman VL, Tuszynski GP. 2010. Thrombospondin-1 (TSP-1) stimulates expression of integrin alpha6 in human breast carcinoma cells: a downstream modulator of TSP-1-induced cellular adhesion. Journal of Oncology 2010:645376. doi: 10.1155/2010/645376
38. Kobayashi YM, Rader EP, Crawford RW, Iyengar NK, Thedens DR, Faulkner JA, Parikh SV, Weiss RM, Chamberlain JS, Moore SA, Campbell KP. 2008. Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 456:511-515. doi: 10.1038/nature07414
39. Kuroda S, Oyasu M, Kawakami M, Kanayama N, Tanizawa K, Saito N, Abe T, Matsuhashi S, Ting K. 1999. Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2. Biochemical and Biophysical Research Communications 265:79-86. doi: 10.1006/bbrc.1999.1638
40. Lapidos KA, Kakkar R, McNally EM. 2004. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circulation Research 94:1023-1031. doi: 10.1161/01.RES.0000126574.61061.25
41. Lavery GG, Walker EA, Turan N, Rogoff D, Ryder JW, Shelton JM, Richardson JA, Falciani F, White PC, Stewart PM, Parker KL, McMillan DR. 2008. Deletion of hexose-6-phosphate dehydrogenase activates the unfolded protein response pathway and induces skeletal myopathy. Journal of Biological Chemistry 283:8453-8461. doi: 10.1074/jbc.M710067200
42. Liu J, Milner DJ, Boppart MD, Ross RS, Kaufman SJ. 2012. b1D chain increases a7b1 integrin and laminin and protects against sarcolemmal damage in mdx mice. Human Molecular Genetics 21:1592-1603. doi: 10.1093/hmg/ddr596
43. Lynch JM, Maillet M, Vanhoutte D, Schloemer A, Sargent MA, Blair NS, Lynch KA, Okada T, Aronow BJ, Osinska H, Prywes R, Lorenz JN, Mori K, Lawler J, Robbins J, Molkentin JD. 2012. A thrombospondin-dependent pathway for a protective ER stress response. Cell 149:1257-1268. doi: 10.1016/j.cell.2012.03.050
44. Malhotra V, Erlmann P. 2015. The pathway of collagen secretion. Annual Review of Cell and Developmental Biology 31:109-124. doi: 10.1146/annurev-cellbio-100913-013002
45. McKeown-Longo PJ, Hanning R, Mosher DF. 1984. Binding and degradation of platelet thrombospondin by cultured fibroblasts. The Journal of Cell Biology 98:22-28. doi: 10.1083/jcb.98.1.22
46. McNally EM, Pytel P. 2007. Muscle diseases: the muscular dystrophies. Annual Review of Pathology: Mechanisms of Disease 2:87-109. doi: 10.1146/annurev.pathol.2.010506.091936
47. Moorwood C, Barton ER. 2014. Caspase-12 ablation preserves muscle function in the mdx mouse. Human Molecular Genetics 23:5325-5341. doi: 10.1093/hmg/ddu249
48. Mori K. 2009. Signalling pathways in the unfolded protein response: development from yeast to mammals. Journal of Biochemistry 146:743-750. doi: 10.1093/jb/mvp166
49. Nakamura K, Yamanouchi K, Nishihara M. 2014. Secreted protein acidic and rich in cysteine internalization and its age-related alterations in skeletal muscle progenitor cells. Aging Cell 13:175-184. doi: 10.1111/acel.12168
50. Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, Lorts A, Brunskill EW, Dorn GW, Conway SJ, Aronow BJ, Robbins J, Molkentin JD. 2007. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling. Circulation Research 101:313-321. doi: 10.1161/CIRCRESAHA.107.149047
51. Paczkowski JE, Richardson BC, Fromme JC. 2015. Cargo adaptors: structures illuminate mechanisms regulating vesicle biogenesis. Trends in Cell Biology 25:408-416. doi: 10.1016/j.tcb.2015.02.005
52. Patterson GH, Hirschberg K, Polishchuk RS, Gerlich D, Phair RD, Lippincott-Schwartz J. 2008. Transport through the Golgi apparatus by rapid partitioning within a two-phase membrane system. Cell 133:1055-1067. doi: 10. 1016/j.cell.2008.04.044
53. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. 2000. Ligand binding to integrins. Journal of Biological Chemistry 275:21785-21788. doi: 10.1074/jbc.R000003200
54. Posey KL, Coustry F, Veerisetty AC, Liu P, Alcorn JL, Hecht JT. 2014. Chondrocyte-specific pathology during skeletal growth and therapeutics in a murine model of pseudoachondroplasia. Journal of Bone and Mineral Research 29:1258-1268. doi: 10.1002/jbmr.2139
55. Schellings MW, van Almen GC, Sage EH, Heymans S. 2009. Thrombospondins in the heart: potential functions in cardiac remodeling. Journal of Cell Communication and Signaling 3:201-213. doi: 10.1007/s12079-009-0070-6
56. Schiller HB, Hermann MR, Polleux J, Vignaud T, Zanivan S, Friedel CC, Sun Z, Raducanu A, Gottschalk KE, Théry M, Mann M, Fässler R. 2013. b1-and av-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments. Nature Cell Biology 15:625-636. doi: 10.1038/ncb2747
57. Shaffer AL, Shapiro-Shelef M, Iwakoshi NN, Lee AH, Qian SB, Zhao H, Yu X, Yang L, Tan BK, Rosenwald A, Hurt EM, Petroulakis E, Sonenberg N, Yewdell JW, Calame K, Glimcher LH, Staudt LM. 2004. XBP1, downstream of Blimp-1, expands the secretory apparatus and other organelles, and increases protein synthesis in plasma cell differentiation. Immunity 21:81-93. doi: 10.1016/j.immuni.2004.06.010
58. Södersten F, Ekman S, Schmitz M, Paulsson M, Zaucke F. 2006. Thrombospondin-4 and cartilage oligomeric matrix protein form heterooligomers in equine tendon. Connective Tissue Research 47:85-91. doi: 10.1080/03008200600584124
59. Stenmark H. 2009. Rab GTPases as coordinators of vesicle traffic. Nature Reviews Molecular Cell Biology 10: 513-525. doi: 10.1038/nrm2728
60. Subramanian A, Schilling TF. 2014. Thrombospondin-4 controls matrix assembly during development and repair of myotendinous junctions. eLife 3:e02372. doi: 10.7554/eLife.02372
61. Subramanian A, Wayburn B, Bunch T, Volk T. 2007. Thrombospondin-mediated adhesion is essential for the formation of the myotendinous junction in Drosophila. Development 134:1269-1278. doi: 10.1242/dev.000406
62. Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K. 1998. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nature Medicine 4:1441-1444. doi: 10.1038/4033
63. Tjondrokoesoemo A, Schips TG, Sargent MA, Vanhoutte D, Kanisicak O, Prasad V, Lin SC, Maillet M, Molkentin JD. 2016. Cathepsin S contributes to the pathogenesis of muscular dystrophy in mice. Journal of Biological Chemistry 291:9920-9928. doi: 10.1074/jbc.M116.719054
64. Wang S, Herndon ME, Ranganathan S, Godyna S, Lawler J, Argraves WS, Liau G. 2004. Internalization but not binding of thrombospondin-1 to low density lipoprotein receptor-related protein-1 requires heparan sulfate proteoglycans. Journal of Cellular Biochemistry 91:766-776. doi: 10.1002/jcb.10781
65. Xu R, DeVries S, Camboni M, Martin PT. 2009. Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice. The American Journal of Pathology 175:235-247. doi: 10. 2353/ajpath.2009.080967
66. Zaal KJ, Smith CL, Polishchuk RS, Altan N, Cole NB, Ellenberg J, Hirschberg K, Presley JF, Roberts TH, Siggia E, Phair RD, Lippincott-Schwartz J. 1999. Golgi membranes are absorbed into and reemerge from the ER during mitosis. Cell 99:589-601. doi: 10.1016/S0092-8674(00)81548-2
67. Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. 2008. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Molecular Therapy 16:1073-1080. doi: 10.1038/mt.2008.76